Fig. 4: Factors differentiating between ELISA+ individuals with and without neutralizing antibodies. | Nature Communications

Fig. 4: Factors differentiating between ELISA+ individuals with and without neutralizing antibodies.

From: Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

Fig. 4

a A higher number of reported symptoms was significantly associated with a higher odds of having neutralizing antibodies. b Loss of appetite, muscle weakness, chills or hot flashes as well as a reduced sense of taste were significantly more often reported by individuals with versus those without neutralizing antibodies. All estimates are adjusted for age, sex and household clustering. The statistical comparisons were between 16 ELISA+/PRNT+ cases and 30 ELISA+/PRNT− control subjects. The red dots represent the odds ratio point estimates, while the whiskers depict the corresponding 95% confidence intervals, on a logarithmic scale.

Back to article page